Cape Biotech's main focus areas and the companies supported within each focus areas are detailed below.

[Health Care]

Point of care diagnostics
The development and manufacturing of novel, cost-effective, easy-to-use, point-of-care diagnostics for major developing world health issues which are relevant to South African Society.

• DISA Vascular
• Centre for Proteomic and Genomic Research (CPGR)

Combination and Conjugate Vaccines
The end-to-end development of medium-cost and volume therapeutic and prophylactic vaccines, to address the key health challenges facing the South African people and developing nations.

• Biovac

Drug Delivery
The development of affordable drug delivery platforms and generic actives, to improve the effectiveness of treatments for first and developing world diseases relevant to South Africa.

• Shimoda

[Bio - Processing]

Nutraceuticals from Biotech Processes
The promotion of the nutraceuticals industries in the Cape, that utilize biotech processes to create employment and export revenues through products which address healthcare and nutritional deficiencies in South Africa and the developing world.

• Natural Carotenoids South Africa (NCSA)
• Cape Carotene
• SunBio
•  

High Throughput Bioprospecting
The development and licensing of novel, natural and new chemical entities (NCEs) to address the key health challenges facing South Africa and other developing nations. Through collaborations, an extensive medical compound library from South Africa’s rich biodiversity will be systematically created, to explore the creation of safe and effective NCEs.

• Kapa Biosystems

Opportunistic
The investment into a high quality, late stage commercial projects, which lie outside the existing focus areas of the trust, but which contribute to the bio-economy.

• Synexa
• BioCareers
• AD Therapeutics